Article
Mutant prevention concentrations of ciprofloxacin against urinary isolates of Escherichia coli and Klebsiella pneumoniae.
Journal of infection in developing countries - 13 Feb 2014
Daoud Ziad, Sokhn Elie Salem, Azar Eid, Masri Khalil, Doron Shira
Abstract excerpt
INTRODUCTION: The aim of this work was to study the ability of ciprofloxacin to restrict the development of resistant mutants of Escherichia coli and Klebsiella pneumoniae through determination of the Mutant Prevention Concentration (MPC). METHODOLOGY: We studied 140 strains of E. coli and 86 strains of K. pneumoniae with different profiles of sensitivity to fluoroquinolones and extended spectrum beta lactamase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
